Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer

London, UK, 1 August 2023: The Cell and Gene Therapy Catapult (CGT Catapult) today announces that Jeanette Evans has been appointed Chief Business Officer (CBO), taking over from Sharon Brownlow, with effect in August 2023. Jeanette is a senior business development executive with over 25 years’ experience in the pharmaceutical industry including working for leading companies such as AstraZeneca and Merck.

Published on the 1st of August 2023. Read the full news report here, Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer

 

 


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (21 février 2024). Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/vvnf


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.